New Consensus Recommendations on Use of Continuous Glucose Monitoring
Real-time CGM and intermittently viewed CGM address many of the limitations inherent in HbA1c testing and self-monitoring of blood glucose.
The new Flash Glucose Monitoring System enables patients to wear the sensor for up to 14 days compared with the existing FreeStyle Libre System that was approved for 10-day wear.
The sensor is coated with a fluorescent chemical which produces a small amount of light when exposed to blood glucose.
Telemedicine could provide real-time feedback loop and allow pharmacists to help patients self-manage.